Search results
Jun 24, 2022 · About Bristol Myers Squibb. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram ...
Our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are focused on helping millions of patients around the world in disease areas such as oncology, haematology, cardiology, immunology, fibrosis and specialty medicines. Through our Research & Development organisation, we have ...
Contact Bristol Myers Squibb through our contact form, customer relations line or live chat. For product side-effect inquiries call (800) 721-5072.
Help paying for your medicines. If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Visit the Bristol Myers Squibb newsroom & stay up to date with our most current news as we continue to make a difference in the lives of our patients.
ブリストル マイヤーズ スクイブ - Bristol Myers Squibb 患者さんへの想いを胸にチャレンジを続ける社員のストーリーを紹介します。 病気と向き合う患者さんのストーリーを紹介します。
Nov 20, 2019 · Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders. Upon completion of the acquisition, pursuant to the terms ...
